Background The estimated incidence of Acute Kidney Injury (AKI) is two to three cases per
1,000 patients. Seven percent of hospitalized patients and about two-thirds of patients in …

Background and Aims: Currently, it is difficult to predict the reversibility of renal function and
to discriminate renal parenchymal injury in cirrhotic patients with acute kidney injury (AKI) …

BACKGROUND We evaluated the applicability of urinary N-acetyl-beta-D glucosaminidase
(NAG) levels in the diagnosis and follow-up in blunt kidney injury. METHODS Twenty …

The role of urinary biomarkers of kidney injury in the prediction of adverse clinical outcomes
in acute renal failure (ARF) has not been well described. The relationship between urinary N …

Background The performance of urinary N-acetyl-β-D-glucosaminidase (uNAG) for the
detection of acute kidney injury (AKI) was controversial. uNAG is positively correlated with …

Background: Urinary N-acetyl-β-d-glucosaminidase (NAG) activity has emerged as
potentially useful early marker of renal tubular injury. This activity is usually evaluated in …

The present observational study was undertaken in order to evaluate the diagnostic value of
urinary N‑acetyl-β-D-glucosaminidase (NAG) for the prediction of acute kidney injury (AKI) in …

Aim Acute kidney injury (AKI) is often underdiagnosed due to several limitations of the renal
marker creatinine. Tubular urinary biomarkers may substantially contribute to diagnose AKI …

N-acetyl-beta-D-glucosaminidase (NAG) is a lysosomal enzyme present in the proximal
convoluted tubules of the kidneys that may be used as a marker of proximal tubular damage …

Urinary enzyme activities, especially N-acetyl-β-D-glucosaminidase (NAG), had been shown
to be a useful early marker of renal injury in clinical diagnosis. 1, 2 NAG is a lysosomal …